Adam Brickner Executive Director Greenville, SC. IntroductionIntroduction.
Chapter 1Chapter 1 IntroductionIntroduction &&&& Review...
Transcript of Chapter 1Chapter 1 IntroductionIntroduction &&&& Review...
Chapter 1Chapter 1Chapter 1Chapter 1
IntroductionIntroductionIntroductionIntroduction &&&&
Review of literatureReview of literatureReview of literatureReview of literature
Introduction and Review of Literature
1
Secondary metabolites are organic compounds that are not directly
involved in the normal growth, development and reproduction of
organisms (Vining, 1992). The functions or importance of these
compounds to the organism is usually of an ecological nature as they
are used to defend against predators, parasites, diseases and for
interspecies competition, to facilitate the reproductive processes
(colouring agents, attractive smells, etc). Prime importance is given to
these compounds as they are produced from restricted group of
organisms. Secondary metabolites may be the likely candidates for
drug or other technological development directly, or as an inspiration
for unnatural products. This will concern secondary metabolites in
plants, bacteria, fungi and many marine organisms (sponges,
tunicates, corals, snails). It is considered that the cell investment in
secondary metabolite production is almost the confirmation of a
function that should give the organisms certain advantage against
other members of the community (Stone and Williams, 1992).
Secondary metabolites are produced from organisms to inhibit other
organism’s competeting for same ecological niche. Secondary
metabolites are produced after active growth of the organism and are
structurally diversified. The distribution of secondary metabolites is
also unique and some metabolites are found in a range of related
microorganisms, while others are only found in one or a few species.
Introduction and Review of Literature
2
The nature has immense potential to provide broad spectrum of
structurally diverse secondary metabolites (Maier et al., 1999). The
structural diversity of secondary metabolites reflects a variety of
biological activities like, antimicrobial agents, inhibitors of enzymes
and antitumor, immunosuppressive and antiparasitic agents (Demain,
1999). Secondary metabolites are generally produced following active
growth, and many have an unusual chemical structure. Some
metabolites are toxic to humans and other animals. Yet others can
modify the growth and metabolism of plants (Griffin, 1994). These
metabolites have been subjected to combinatorial chemistry following
growth in selective media. Interestingly, the most important secondary
metabolites seem to be synthesized from one or a combination of the
biosynthetic pathways: polyketides arising from Acetyl Coenzyme A,
mevalonate pathway that also arises from Acetyl Coenzyme A, and
from amino acids. In addition, genes for the synthesis of some
important secondary metabolites are found clustered together, and
expression of the cluster appears to be induced by one or a few
regulators (Cox, 2007).
1.1 MICROORGANISMS AS SOURCE OF SECONDARY
METABOLITES
History of microbial biotechnology reveals that many desirable
materials like foods, beverages, pesticides and antibiotics were
produced using microorganisms. The studies of Louis pasture for the
Introduction and Review of Literature
3
production of penicillin in the nineteenth century results in the
exploitation of microorganisms for valuable metabolites.
Microorganisms are considered as miniatures of chemical factories. In
the 1940’s the discovery of penicillin by Louis pasture initiated
researchers for the exploitation of microorganisms for the production
of secondary metabolites, which revolutionized the field of
microbiology (Demain and Fang, 2000). Inspite of this, until 1970 only
two classes of naturally occurring β-lactam antibiotics, penicillins and
cephalosporins, were known. With the advent of new screening and
isolation techniques, a variety of β-lactam-containing molecules (Wells
et al., 1992) and other types of antibiotics have been identified.
With the emergence of new diseases, screening of microorganisms
for the production of new antibiotics has rapidly increased during the
last three decades. The majority of studies were focused on the
exploitation of antibiotics from fungi and actinomycetes, which are
capable of producing secondary metabolites with widely divergent
chemical structures.
Parallel to the screening for new antibiotics, efforts have been
focused in finding low molecular weight secondary metabolites with
other biological activities. Among others, secondary metabolites with
activity as enzyme inhibitors, plant growth stimulators, herbicides,
insecticides, antihelminthics and immunosuppressant’s have been
obtained. Two main strategies have been used during the screening of
Introduction and Review of Literature
4
microbes for the isolation secondary metabolites. The first strategy is
to isolate the known secondary metabolites to evaluate the biological
activities not mentioned in the literature and the second one is to
isolate novel secondary metabolites with various biological activities.
Most of the secondary metabolites were used in the clinical practice as
antibiotics. Some metabolites like mithramycin, bleomycin,
daunomycin and adriamycin were used as antitumor compounds
(Kieslich, 1986). Other properties of secondary metabolites are
anabolics, anesthetics, anticoagulants, anti-inflammatories,
immunosuppressants (cyclosporine-A and tacrolimus), hemolytics,
hypocholesterolemics (statin), and vasodilatories (Bentley, 1997).
More than 23,000 bioactive metabolites of which 17,000 antibiotics
were discovered from the microorganisms in the last 50 years (Janos
Berdy, 2005). Microbial secondary metabolites have specific and
complex chemical structures, with fascinating array of diverse and
unique functional groups. Studies on secondary metabolites revealed
the fact that the microbial secondary metabolites have unique
molecular skeleton which is not found in the chemical libraries which
makes the chemist unable to synthesize more than 40% of the
metabolites (Feher and Schmidt, 2003).
Filamentous microorganisms such as fungi and actinomycetes are
the main source of secondary metabolites with antibiotic activity. The
filamentous microorganisms freshly isolated from soil are the best
Introduction and Review of Literature
5
source of secondary metabolites. Some isolates of several
Streptomyces species able to produce more than 180 different
secondary metabolites (Demain and Fang, 2000).
In the group of bacteria, genus Bacillus produces more number of
secondary metabolites. Wide varieties of antibiotics such
moenomycins, difficidins, bacillomycins and bacillaenes have been
isolated from different strains of Bacillus (Patel et al., 1995; Zweerink
and Edison, 1987). Apart from Bacillus, Myxobacterium is another
genus which produces more number of antibiotics. Approximately
80% of the isolated Myxobacteria produced secondary metabolites
with antibiotic activity, many of them exhibiting antifungal activity
(Dolak et al., 1983).
1.2 BIOACTIVITIES OF MICROBIAL SECONDARY METABOLITES
Secondary metabolites produced from microorganisms exhibit
various types of biological activities. The secondary metabolites
produced from microorganisms with incredible array of chemical
structures results in the versatile biological activities. The scope of
search for various bioactive microbial products had however
broadened. The exploration and wide utilization of the antitumor
(doxorubicin) and agricultural antibiotics, (antiparasitic avermectin,
feed additive monensin and herbicide glufosinate), the early
discoveries of utilization of microbial metabolites in the
pharmacological fields (cyclosporin, statins), were important new
Introduction and Review of Literature
6
features in the exploitation of microorganisms (Maplestone et al.,
1992). In general secondary metabolites produced from
microorganisms are used in agriculture and medicine directly or used
in the chemical/biological derivitization or used in the rational drug
design.
1.3 BIODIVERSITY AND CHEMICAL DIVERSITY OF
MICROORGANISMS
Biodiversity is usually referring to the number of species (or other
taxonomical entities) in a given ecosystem or geographic area.
Biodiversity is defined as concerning those biological species that are
studied specifically for their value as producers of organic compounds,
so-called secondary metabolites. These compounds are isolated,
characterized and studied by chemists and biologists to evaluate their
biological, pharmacological/chemotaxonomic potential, or simply to
explore chemical diversity.
Till date about 6,000 species of prokaryotes especially bacteria are
known and it is estimated that 106 to 109 bacterial strains exist in the
nature (Ward, 2002). About 70,000 fungal species are known and
expecte to be present at the rate of 1.5 × 106 species in the nature
(Hawksworth, 1991). The above calculation of unexploited
microorganisms provides a hope to the researchers for the exploitation
of secondary metabolites from them. The number of metabolites from
filamentous organisms i.e. actinomycetes and fungi are tremendous
Introduction and Review of Literature
7
and accounts for 19,000 molecules representing 60% of total bioactive
microbial secondary metabolites (Berdy, 2005). In fungi certain genera
such as Penicillium, Aspergillus, Trichoderma and Fusarium are the
frequent producers of secondary metabolites (Pelaez and Genilloud,
2003). Fungi are highly diversified microorganisms. Various fungi like
terrestrial fungi, endophytes, entomopathogenic, nematode trapping,
coprophilous, marine and freshwater fungi represents the ecological
diversity (Collado, et al., 2001). New species and even major taxa of
fungi and actinomycetes are being discovered every day, opening
windows of opportunities and providing evidence that our knowledge
of these microorganisms is far from exhaustive.
1.4 BIOTECHNOLOGICAL IMPORTANCE OF FUNGI
Fungi are the most important biotechnologically useful organisms
(Kurtzman, 1983). Fungi have been used to elucidate the complex
biochemistry and genetic principles of eukaryotes. They are important
not only for antibiotics, but also used in commercial production of
flavoring foods, production of biochemicals such as organic acids and
enzymes (Blain, 1975; Eveleigh, 1981). The fungal kingdom offers
enormous biodiversity, with around 70,000 known species, and an
estimated 1.5 million species in total. Most of these are filamentous
fungi, which differ from the yeasts not only in their more complex
morphology and development (e.g. asexual and sexual structures), but
also in their greater metabolic complexity. In particular, they are
Introduction and Review of Literature
8
known for production of enzymes and secondary metabolites. Of the
12,000 antibiotics known in 1995, about 22% could be produced by
filamentous fungi (Berdy, 1995).
Antibiotics like penicillin, teteracyclin, cephalosporin and
immunosuppressive agent like cyclosporine-A was reported from fungi
in the early days of antibiotic research. The first known secondary
metabolite mycophenolic acid was never used as an antibiotic where
as its ester, 2-morpholinoethylester was commercialized as
immunosuppressive agent. Lovastatin and pravastatin used as
hypocholesterolemic agents are also of fungal origin (Endo, 1985).
Antitumor agent taxol was also reported to be produced from fungus
Taxomyces andreanae (Stierle et al., 1993). Fermented rice with
Monascus purpureus used as a chinese traditional medicine contains
monascorubramine and rubropunctamine (Juzlova et al., 1996). The
highly valuable product astaxanthin was exploited from Phaffia
rhodozyma (Andrewes et al., 1976).
Ascomycetes and fungi imperfecti are the most frequent producers
of secondary metabolites accounting for 6400 compounds. Aspergillus,
Penicillium and Fusarium species produce 950, 900 and 350
compounds respectively from the group representing ascomycetes.
Basidiomycetes or mushrooms produce 2000 active compounds. From
Introduction and Review of Literature
9
yeasts, only 140 and from Myxomycetes (slime moulds) species 60
bioactive metabolites have been isolated (Janos Berdy, 2005).
1.4.1 IMPORTANCE OF FUNGI IN AGRICULTURE
Microbial metabolites have advantage over the synthetic pesticides.
Chemical pesticides cause environmental pollution and impose
deleterious effects on human health. The microbial metabolites are
host specific and have broad range of activity. Synthetic pesticides are
also the derivatives of secondary metabolites. These secondary
metabolites are used as antifeedents, anti parasitic, insecticides,
antihelminthic agents, cestocides, acaricides, nematocides, antiworm
compounds, phytotoxins, plant growth regulators, germination
inhibitors, allelochemicals, phytohormones, chlorosis inducers,
algicides, and other biocontrol agents. Avermectin, monensin and
bialaphos are the most useful microbial compounds in this group.
In agriculture attempts are being made to use fungi as biocontrol
agent to reduce the damage of insects and weeds (Adams, 1988) and
pathogenic microorganisms (Burge, 1988; Gellespic, 1988) and as an
inoculants or biofertilizers to improve crop yield (Lynch et al., 1991;
Whips and Lumpsden, 1989). Association of mycorrhizal fungi
provides an intimate link between soil and nutrient absorbing organs
of plants and optimizes the uptake of phosphorous and increases the
yield (Khan, 1972; Harley, 1989).
Introduction and Review of Literature
10
Table 1.1: Secondary metabolites produced by microorganisms and their biological activities
Microorganism Metabolite Bioactivity
Acremonium chrysogenum Cephalosporin Antibacterial Streptomyces clavuligerus Cephamycin Antibacterial Streptomyces venezuelae Chlormomphenicol Antibacterial Streptomyces erythraea Erythromycin Antibacterial Streptomyces aureofaciens Tetracyclin Antibacterial Penicillium chrysogenum Penicillin Antibacterial Amycolatopsis mediterranel Rifamycin Antibacterial Streptomyces spectablis Spectinomycin Antibacterial Streptomyces griseus Streptomycin Antibacterial Streptomyces niveus Novobiocin Antibacterial Micromonospora Gentamicin Antibacterial Zygosporium mansonii Zygosporin-A Antibacterial Streptomyces nodosus Amphoteracin Antifungal Aspergillus flavus Aspergillic acid Antifungal Streptomyces aureofaciens Aureofacin Antifungal Streptomyces griseus Candicidin Antifungal Penicillium griseofulvin Griseofulvin Antifungal Streptomyces nourse Nystatin Antifungal S. diastachromogenes Oligomycin Antifungal Streptomyces antibioticus Actinomycin-D Antitumor Streptomyces verticilus Bleomycin Antitumor Streptomyces speuceticus Doxyrubicin Antitumor Streptomyces lavendulae Mitomycin-C Antitumor Taxomyces andreanae Taxol Antitumor Streptomyces clavuligerus Clavulanic acid Plant enzyme inhibitor Gibberella fujikuroi Gibberelin Plant growth regulator
Continued in next page…
Introduction and Review of Literature
11
Microorganism Metabolite Bioactivity
Streptomyces cinnamonensis Monensin Growth promoter Streptomyces fradiae Tylosin Growth promoter Streptomyces hygroscopicus Bialaphos Herbicidal Streptomyces avermitilis Avermectin Insecticidal Streptomyces hygroscopicus Milbemycin Insecticidal Phaffia rhodozyma Astraxanthin Pigment Monascus purpureus Monascin Pigment Trichoderma flavofuscum L-DOPA Parkinson's disease Phycomyces blakesleeanus Ferritin Nutrient Ashybya gossypii Riboflavin Nutrient Altrenaria arborescens Alternariols Mycotoxin Aspergillus Parasiticus Aflatoxins Mycotoxin Penicillium verrucosum Ochratoxin-A Mycotoxin Claviceps purpurea Ergotamines Mycotoxin Aspergillus and Penicillium Patulin Mycotoxin Fusarium Sps Fumonisins Mycotoxin Fusarium Sps Zearalenone Mycotoxin Fusarium and trichoderma Trichothecenes Mycotoxin Aspergillus terrus Lovastatin Anticholestrolemics Monascus ruber Monacolin Anticholestrolemics Penicillium citrinum Pravastatin Anticholestrolemics Beauvaria nivea Cycloporines Immunosuppressive Aspergillus and trichoderma Gliotoxin Immunosuppressive Tolypocladium iflatum Cyclosporin-A Immunosuppressive Streptomyces hygroscopicus Rapamycin Immunosuppressive
Introduction and Review of Literature
12
1.4.2 USE OF FUNGAL METABOLITES AGAINST PLANT DISEASES
Secondary metabolites play important role in the control of plant
pathogens. These are used to control the phytopathogenic fungi and
bacteria (Burge, 1988). Trichoderma harzianum produces an
antifungal agent, alkyl-pyrone which is active against wide range of
fungi and bacteria (Claydon et al., 1987). Pisolithus arhizus produce
compounds, hydroxy benzyl formic acid and R-(-)-p-hydroxymendelic
acid active against Truncatella hartigii (Kope et al., 1991). Most of the
Trichoderma sps. produce gliotoxin active against root pathogenic
fungus Rhizoctonia solani (Dennis and Webster, 1971; Harman et al.,
1980). Gliotoxin is also isolated from Gliocladium species active
against wood-rotting fungus, Armillarriab mellea (Lumsden et al.,
1991, 1992).
Trichoderma viridae and Peniophora gigantean are the two fungi
successfully exploited and commercialized against plant pathogenic
fungi. Trichoderma viridae has been used to control Armillaria mellea
on trees, Cerotocystis ulmi on elm, Chondrosterium purpureum on fruit
trees and Eucalyptus and Heterobasidium annosum on pine (Ricard
and Highley, 1988), which parasitizes hyphae of the pathogenic fungi
and produces secondary metabolites (Dennis and Webster, 1971).
Peniophora gigantean is used to control infestation caused by
Heterobasidium annosum, root rot of pines (Lynch, 1990).
Introduction and Review of Literature
13
Coniothyrium mimitans parasitizes sclerotia of Sclerotium
trifoliarum, Sporidesmium sclerotivorum and Sclerotinia minor (Ayers
and Adams, 1979). Rhizoctonia solina was reported to be parasitized
by Gliocladium virens (Howell, 1987) and it also protects damping off
caused by Pythium ultimum and Rhizoctonia solina (Howell, 1982).
Ampelomyces quisqualis is used to prevent powdery mildews (Chet,
1990). Verticellium chlymadosporium showed strong inhibitory effect
on M. phaseolina, R. solani and F. solani both in vitro and in vivo
(Ehteshamul-Haque., et al., 1994). Talaromyces flavus which
parasitizes hyphae of Rhizoctonia solina (Boosalis, 1956) also inhibits
the growth of other fungi (Dwivedi and Garrette, 1968; Husain and
McKeen, 1963). Similarly Verticellium chlymadosporium possess
antibacterial activity (Marchisio, 1977) and was found to parasitize
oospore of Phytophthora cactorum (Sneh et al., 1977). Now a day’s
Fusarium oxysporum received attention as a biocontrol agent. Been rot
caused by Fusarium solani and infection in red clover decreased by
non pathogenic Fusarium oxysporum (Lechappe et al., 1988).
1.4.3 FUNGAL SECONDARY METABOLITES AGAINST PLANT
PARASITIC NEMATODES
Soil contains various nematophagous fungi which are natural
enemies to nematodes. Large number of nematophagous fungi with
significant nematicidal activity have been discovered so far (Dayal,
2000). Paeciomyces lilacinus infects eggs of Meloidogyne incognita
Introduction and Review of Literature
14
(Jatal, 1985 & 1986). Vericillium chamydosporium also showed
significant activity against the cysts of Meloidogyne spp. and
Heterodera spp. (De Leji, 1992; Kerry, 1990). The hatching of
nematode cysta, Globodra pallaada was adversely affected by the fungi
like Ulocladium Botrytes, Drechslera spp., Gliocladium spp., and
Trichurus spp (Gonazales et al., 1984). The fungus Paecilomices
lilacinus was also widely tested for nematode control (Wainwright,
1992). Penicillium anatolicum produces compounds that acts on the
eggs of nematodes (Jatala, 1986).
1.4.4 FUNGAL METABOLITES AS INSECTICIDAL COMPOUNDS
The use of chemical pesticide and other agro chemicals are getting
reduced / being banned globally because of their toxic effects on
human beings and his live stock, residual toxicity, environmental
problems, pest outbreaks and drastic effects on beneficial insects.
Microbial pesticides have advantage over the synthetic pesticides.
Most of the compounds practiced in agriculture are the derivatives of
the natural products.
Various formulations of microbial pesticides are commercially
available. Formulations of Bacillus thuringiensis, Trichoderma sps,
Metarhizium sps, Beauveria sps, Verticillium sps and Baculovirus are
used against agriculture pests, Helicoverpa & Spodoptera and
commercially available in India.
Introduction and Review of Literature
15
Table 1.2: List of metabolites isolated from fungi from 1998-2003 and their biological activity*
Metabolite Produced by Activity Year
Trichodenone Trichoderma harzianum Antitumor 1998
Harzialactone Trichoderma harzianum Antitumor 1998
Glisoprenin Gliocladium roseum Antifungal 1998
Curvularin Aspergillus sps Biological 1998
Longibrachin Trichoderma longibrachiatum Antibacterial 1998
Trichorzin Trichoderma harzianum Antibacterial 1998
Pyrenocine Penicillium waksmanii Antitumor 1998
Aranochlor Pseudoarachniotus roseus Antifungal 1998
Terprenin Aspergillus candidus Biological 1998
Haematocin Nectria haematococca Antifungal 2000
Arisugacin Penicillium sps Biological 2000
Curtisian Paxillus curtisii Biological 2000
Melleolide Armillariella mellea Antibacterial 2000
Roseoferin Mycogone rosea Antifungal 2000
Chaetoatrosin-A Chaetomium atrobrunneum Antifungal 2000
Strobilurin Mycena galericulata Antiparasitic 2000
Topopyrone Phoma sps Antitumor 2000
Phellinsin-A Phellinus sps Antifungal 2000
Xanthoepocin Penicillium simplicissimum Antifungal 2000
Neobulgarone Neobulgaria pura Agricultural 2000
Ampullosporin Sepedonium ampullosporum Biological 2001
Continued next page..
Introduction and Review of Literature
16
Metabolite Produced by Activity Year
Phoenistatin Acremonium Fusigerum Antitumor 2001
Cephaibol Acremonium Tubakii Antiparasitic 2001
Epicorazine-C Stereum Hirsutum Antibacterial 2001
Spirobenzofuran Acremonium sps Antibacterial 2001
Cladospolide-D Cladosporium sps Antifungal 2001
Lucilactaene Fusarium sps Antitumor 2001
Bisabosqual-D Stachybotrys ruwenzoriensis Antifungal 2001
Altersetin Alternaria sps Antibacterial 2002
Chrysoqueen Chrysosporium queenslandicum Antibacterial 2002
Chrysolandol Chrysosporium queenslandicum Antibacterial 2002
Thielavin Chaetomium carinthiacum Biological 2002
Miyakamide Aspergillus flavus Others 2002
Phenylpyropene Penicillium griseofulvum Biological 2002
Ustilipid Ustilago maydis Biological 2003
Coniosetin Coniochaeta ellipsoidea Antibacterial 2003
Asperaldin Aspergillus niger Biological 2003
Terreulactone Aspergillus terreus Biological 2003
Quinocitrinine-B Penicillium citrinum Antibacterial 2003
Monorden Humicola sps Biological 2003
Malbranicin Malbranchea cinnamomea Antifungal 2003
Acremonidin Acremonium sps Antibacterial 2003
Exophillic acid Exophiala pisciphila Antiviral 2003
*According to “Novel antibiotics data base” The Journal of Antibiotics;
http://www.antibiotics.or.jp/journal/database/database-top.htm
Introduction and Review of Literature
17
Entamopathogenic fungi kill the host by inhibiting the growth &
development of insect. Entamopathogenic fungi are widely used
against lepidopteran pests (Balasubramanian, 1994).
Entomopathogenic fungi, Beauveria bassiana and Metarhizium
anisopliae are highly active against various insects and the
formulations are available in the market. Fungal secondary
metabolites with insecticidal activity like Avermectins, destruxins,
ibotenic acid, pantherine, and tricholomic acid are highly active
(Huang and Shapiro, 1971).
Versimide and methyl-α-(methylsuccinimido)acrylate produced
from Aspergillus versicolor are contact insecticides. Acetylene and
furanocoumarins act as inhibitors of acetylcholine esterase, a
neurotransmitter. Tenuazonic acid and diacetoxyscirpenol produced
from Alternaria tenuis and Fusarium lateritium respectively showed
larvicidal activity. Thiolutin, cycloheximide, rubratoxin, patulin,
trichothecin, actinomycin, and scirpene produced by fungi also had
insecticidal activity.
1.5.1 FUNGAL METABOLITES AS ANTIBIOTICS
Antibiotics are the heterogeneous organic molecules of microbial
origin and deleterious to the growth and metabolic activities of other
microorganisms (Thomashow and Weller, 1995). Antibiotic research is
the most important field in the microbial biotechnology to produce
compounds against pathogenic microorganisms. Antibiotics represent
Introduction and Review of Literature
18
greatest contribution of drug therapy (Robbers et al., 1996). The
process of new drug discovery is driven largely by the desire to identify
a structurally novel compound that possesses novel and potentially
useful biological activity (Stephen and Horce, 2000).
5.1.1 FUNGAL METABOLITES AS ANTIMICROBIAL AGENTS
Penicillium vericulum produce a vermiculin with antiprotozoal
potential (Fuska et al., 1972). The compound As-186 from Penicillium
asperosporium exihibit acyl-CoA:cholesterol acyltransferase (ACAT)
activity. Lovastatin reported from Aspergilus terrus is used in the
inhibition of cholesterol biosynthesis (Kuroda et al., 1994). Lovastatin
related compounds were isolated from P. brevicompactum and P.
citrinum (Endo et al., 1976). Arohynapenes A and B, anticoccidial
agents (Masuma et al., 1994) were reported from Penicillium sps.
Alfavarin and β-aflatrem, a new antisectan metabolite was isolated
from the sclerotia of Aspergillus flavus (TePaske et al., 1992).
Fusarium solani is known to produce toxin like Neosalaniol, T-2 toxin,
HT-2 toxin diacetoxyseripenol (Ueno and Nishimura, 1973) and
fusarubin reported to have antimicrobial (Arnstein, et al., 1946),
antitumor (Issaq et al., 1977), and phytotoxin activitivities (Kern,
1970). Apart from clinical uses the metabolites produced from
microorganisms are also used as growth stimulant and in the control
of plant diseases (Evans, 1989).
Introduction and Review of Literature
19
Fungi produce various types of metabolites used in current
chemotherapy, for example penicillin, cephalosporin and fusidic acid,
which have antibacterial and antifungal activity (Lowe and Elander,
1983). After the discovery of penicillin in 1928 from P. notatum, the
modern era in the research of antibiotics started. A number of
antibiotics have been isolated from microorganisms with a ratio of
70:20:10 from actinomycetes, fungi and eubacterials respectively
(Bredy, 1974). Antibiotics like cephalomycin-C from Streptomyces
lactamdurrans, bacitracin from Bacillus subtilis, and tetracycline from
Streptomyces erythreus and kanamycin from Streptomyces
kanamyceticus (Tyler et al., 1988) produced and used in medicine.
Tolypocladium inflatum and T. geodes as well as strains of
Acremonium, Beauvaria, Fusarium, Paecilomyces and Verticillum Sps
(Dreyfus et al., 1976; Good et al., 1985) were know to produce
Cyclosporine-A. Multipliolides-A and B, 10-membered lactose
compounds were produced from Xylaria mutiplex (Boonphong et al.,
2001).
Most of the β-lactam antibiotics like pencillin, cephalosporin and
their relatives are produced from Penicillium and Cephalosporium
group where as polyene antibiotics are produced from Aspergillus sps
(Egoron, 1985). Griserofulvin is a metabolic product of Penicillium
nigricans, P. urticae and P. raistrickii used as therapeutic agent in the
treatment of dermatomycosis (Brain, 1960).
Introduction and Review of Literature
20
The genus Streptomyces of actinomycetes is most potent producers
of antibiotics. They produce antibiotics like tetracyclins,
aminoglycosides, macrolides, ivermectin, rifamycin and others. Other
strains of actinomycetes such as Actinoplanes, Streptosporangium,
Nocardia, Streptoverticillium, and Micromonospora also produce
antibiotics. Bacillus polymyxa produce polymyxin and Bacillus subtilis
produce bacitracin, which belongs to polypeptide group. Zwittermicin
is produced by Bacillus cereus, where as nisin and thryothricin is
produced by Streptococcus lactis. Eubacteriales produce more number
of antibiotics in which Bacillus accounts for 70% and 13% for
Pseudomonas (Hugo and Russell, 1998).
Fusarium solani and Fusarium oxysporum produces several
napthaquinones with antibacterial properties (Baker, 1990). From
Talaromyces flavus, azole fungicide FKI-0076 was isolated. Fusidic
acid and fucidin produced from Acromonium fusidioides have anti
bacterial activity against gram negative bacteria (Godtfredson and
Lorck, 1963). An antibiotic, botrydiplodin produced by Botryosphaeria
rhodina was found active against both Gram-positive and Gram-
negative bacteria (Sen Gupta et al., 1966).
Cochliodinol produced by Chaetomium cochlioides exhibit both anti
bacterial and antifungal activities whereas chaetomin was active
against gram positive bacteria (Brewer et al., 1970). Cryptosporiopsis
guercina produce crytocandin, a lipopeptide antibiotic showed strong
Introduction and Review of Literature
21
inhibitory activity against human pathogenic fungi like Candida
albicans, Trichophyton mentagrophytes, Trichophyton rubrum and
plant pathogenic fungi like Sclerotinia sclerotium and Botrytis cinerea
(Strobel et al., 1999). Epidithiadiketo-piperazine and chaetomin
produced by Chaetomium globosum showed strong antifungal activity
(DiPietro et al., 1992). Glioclabium virens produced compounds,
gliovirin having antibiotic activity towards Pythium ultimum (Howell
and Stipanovic, 1983) and viridian, fungistatic in nature (Jones and
Hancock, 1987).
1.5.2 FUNGAL METABOLITES AS ANTITUMOR AGENTS
Apart from antibiotics compounds such as steroid derivatives,
ergot alkaloids, immnoregulators and antitumor agents were isolated
from fungi. Aspergillus sps., produce several quinine antitumor agents
(Sultan and Ahmad, 1994). Fusarium griseum produce fusidienol
which inhibits farnesyl protein kinase transferase responsible for
cancer (Singh et al., 1994). A potent protein kinase-C inhibitor,
Balanol, is produced by Verticillium balanoides (Kulanthaviel et al.,
1993). Antitumor compounds such as SCH-49210, 53516 were
reported from Naurassia mangifera and Preussia isomera (Chu et al.,
1994; Weber et al., 1990).
Myrothecium sp. produce roridins having cytotoxic activity against
colon tumor cell lines (wagennar and Clardy, 2001). Cytotoxic
Introduction and Review of Literature
22
compound Viscoltricin produced from Fusarium tricinctum inhibits the
growth of several human tumor cell lines (Visconti and Solfrizzo,
1995). Pentostatin, peplomycin, and epirubicin are the commercialized
antitumor agents isolated from fungi (Butler, 2005). Taxomyces
andreanea was the first endophytic fungus that was found to produce
taxol and taxane. Pestalotiopsis microspora produce high amount of
taxol. On the other hand may be useful in producing taxol much more
cheaply. Other fungi like Nodulisporium sylviforme and Taxodium
distichurn also produces taxol (jia yao et al., 1996).
Increased clinical needs, multi drug resistance strains, new
emerging pathogens, neoplastic and viral diseases led to the search for
discovery of new pharmacophores. In the agriculture field to prevent
the fungal pests and pathogens there is a need to discover newer
metabolites with high biological activity. The present work describes
the screening of various indigenously isolated fungal strains for the
isolation of bioactive secondary metabolites. Further the extracts were
bioassayed for antimicrobial against a panel of microorganisms and
larvicidal activity against agriculture pest Spodoptera litura. The
results showed, fungi Aspergillus funiculosus, A. gorakhpurensis and
Curvularia oryzae were found to be active. Ethyl acetate extracts were
further purified by chromatographic techniques and fractions were
isolated. Structures of the isolated fractions were determined by NMR
and mass spectral data. The isolated compounds were bioassayed for
Introduction and Review of Literature
23
antibacterial, antifungal and larvicidal activities. The mode of action of
the isolated compounds was established against bacteria and S. litura
larvae.
Introduction and Review of Literature
24
AIM OF THE STUDY
The main aim of this study is to isolate bioactive secondary
metabolites from fungi with antibacterial, antifungal and insecticidal
efficacy.
To achieve this goal the following specific objectives were pursued
� Screening of fungal species for their antimicrobial and larvicidal
efficacy
� Large scale cultivation of the lead fungi
� Isolation and chemical characterization of the secondary metabolites
from Aspergillus funiculosus, Aspergillus gorakhpurensis and
Curvularia oryzae
� Bioevaluation of the isolated compounds against bacteria, fungi and
Spodoptera litura larvae
� Determination of mode of action of metabolites against bacteria and
insect larvae (S. litura)